Loading...
Loading...
Browse all stories on DeepNewz
VisitElon Musk's Neuralink Introduces 'Telepathy,' Promises Superpowers and Telepathic Communication for 10 Patients
Jul 10, 2024, 06:15 PM
Elon Musk and the Neuralink team provided a live update on their brain-computer interface technology. The first product, named 'Telepathy,' was introduced, and a second patient is expected to receive a device within a week. Musk announced that Neuralink aims to have around 10 patients by the end of 2024, with thousands projected in the coming years. The technology promises to enable telepathic communication, allowing users to communicate faster than traditional methods. Musk emphasized that the device minimizes brain damage and patient load, aiming to enable individuals to live completely normal lives. The update also highlighted the potential for disabled individuals to control robotic limbs and perform daily tasks through brain signals. Musk also mentioned that the technology could give people 'superpowers' and enable communication with Optimus robots.
View original story
Yes • 50%
No • 50%
Restoring eyesight to a blind individual • 25%
Enhancing vision for partially sighted individuals • 25%
Other medical applications • 25%
No application by end of 2024 • 25%
2024 • 25%
2025 • 25%
2026 • 25%
Not by 2026 • 25%
Telepathic communication • 25%
Enhanced cognitive functions • 25%
Control of robotic limbs • 25%
Curing paralysis • 25%
Yes • 50%
No • 50%
Productivity Software • 25%
Entertainment Software • 25%
Educational Software • 25%
Other • 25%
Yes • 50%
No • 50%
Medical (e.g., helping paralyzed individuals) • 25%
Gaming • 25%
Communication • 25%
Other • 25%
2025 • 25%
2026 • 25%
2027 • 25%
2028 or later • 25%
Restoration of hand movement • 25%
Restoration of leg movement • 25%
Improvement in speech • 25%
Other • 25%
Drawing Software • 25%
Music Production Software • 25%
Video Editing Software • 25%
Other • 25%
Assistive technology for paralysis • 25%
Cognitive enhancement • 25%
Medical treatment for neurological disorders • 25%
Other • 25%
10-14 • 25%
15 or more • 25%
0-4 • 25%
5-9 • 25%